The Role of Clinical Pharmacists in Modifying Cardiovascular Disease Risk Factors

The Role of Clinical Pharmacists in Modifying Cardiovascular Disease Risk Factors

Objective: Assess the effect of intensive clinical and educational interventions aimed at reducing risk factors for Cardiovascular Disease (CVD), implemented by clinical pharmacists, on modifying risk factors in targeted patients at high risk for CVD.Design: Patients with at least two risk factors f...

Full description

Bibliographic Details
Main Authors:	DeeAnn Dugan, PharmD, BCAP, Autumn Bagwell, PharmD., Jessica W. Skelley, PharmD, Lana Saad, PharmD, Thomas Woolley, PhD
Format:	Article
Language:	English
Published:	University of Minnesota Libraries Publishing 2013-01-01
Series:	INNOVATIONS in Pharmacy
Subjects:	Cardiovascular Disease hypertension diabetes modifiable risk factors obesity smoking status physical activity hyperlipidemia
Online Access:	http://www.pharmacy.umn.edu/innovations/prod/groups/cop/@pub/@cop/@innov/documents/article/cop_article_457094.pdf

Similar Items

Social Media and Unprofessional Pharmacist Conduct: A Cross-Sectional Survey of Boards of Pharmacy
by: Lindsey Elmore, PharmD, BCPS, et al.
Published: (2013-01-01)

The Effect of Pharmacist Intervention on Diabetes Screening Promotion and Education in a Geriatric Population
by: Ann Ryan-Haddad, PharmD, et al.
Published: (2012-01-01)

Lifestyle Medicine-Related Cardiovascular Risk Factor Changes in Employees Participating in a Pharmacist-Run Risk Reduction Program
by: Yongyue Qi, et al.
Published: (2012-01-01)

Adverse childhood experiences among California student pharmacists
by: Shawn R. Smith, PharmD, APh, et al.
Published: (2024-02-01)

Project ImPACT: Hypertension Outcomes of a Pharmacist-Provided Hypertension Service
by: Carrie Wentz Nemerovski, PharmD, BCPS, et al.
Published: (2013-01-01)

Medication Adherence Improvements in Employees Participating in a Pharmacist-Run Risk Reduction Program
by: Jessica J. Skradski, PharmD, et al.
Published: (2012-01-01)

Pharmacist Prescriptive Authority for Epinephrine Auto-Injectors in Idaho
by: Alex J Adams, PharmD, MPH
Published: (2016-10-01)

Implementing a Pharmacist-Led Medication Management Pilot to Improve Care Transitions
by: Rachel Root, PharmD, MS, et al.
Published: (2012-01-01)

Implementation and Impact of Critical Care Pharmacist Addition to a Telecritical Care Network
by: Rachel M. Belcher, PharmD, BCCCP, et al.
Published: (2023-01-01)

Health-Related Quality of Life Impact in Employees Participating in a Pharmacist-Run Risk Reduction Program
by: Yongyue Qi, et al.
Published: (2012-01-01)

Systematic literature review of the impact of psychiatric pharmacists
by: Jessica L. Ho, PharmD, BCPP, BCPS, et al.
Published: (2024-02-01)

Potential role of a pharmacist to enhance medication-related aspects of clinical trials conducted in a dedicated clinical research unit
by: Kimberly A. Redic, PharmD, et al.
Published: (2017-06-01)

Addition of a clinical pharmacist practitioner to an inpatient addiction triage team and related medication outcomes
by: Kim Ehrhard, PharmD, BCPP, et al.
Published: (2023-08-01)

Positioning psychiatric pharmacists to improve mental health care
by: Julie A. Dopheide, PharmD, BCPP, FASHP, et al.
Published: (2022-04-01)

Pharmacist impact on medication reconciliation of behavioral health patients boarding in the emergency department
by: Mary Accomando, PharmD, BCPP, et al.
Published: (2022-06-01)

Implementation of a Pharmacist-Directed Cardiovascular Risk and Medication Management Program for Participants in a Construction Trade Benefit Trust Fund
by: Yifei Liu, PhD, et al.
Published: (2010-01-01)

Impact of a pharmacist-driven tardive dyskinesia screening service
by: Niyati Butala, PharmD, BCPP, et al.
Published: (2021-07-01)

Attitude and Perception of Physicians and Nurses Toward the Role of Clinical Pharmacists in Riyadh, Saudi Arabia: A Qualitative Study
by: Nada Alsuhebany BSPharm, PharmD, et al.
Published: (2019-11-01)

A Veterans Affairs' perspective in response to Best Practice Model Subcommittee attribute statements for outpatient psychiatric pharmacists
by: Jonathan F. Lister, PharmD, BCPP, et al.
Published: (2022-11-01)

Impact of Board Certified Psychiatric Pharmacists on improving urinary tract infection antibiotic appropriateness at an acute psychiatric hospital
by: Hamad Mohammad Adam PharmD, BCPS, et al.
Published: (2023-10-01)

The Role of Ambulatory Care Pharmacists in an HIV Multidisciplinary Team within a Free and Bilingual Clinic
by: Ann M. Fugit, Pharm.D., BCPS, et al.
Published: (2013-01-01)

Specialty pharmacist integration into an outpatient neurology clinic improves pimavanserin access
by: Sabrina Livezey, PharmD, CSP, et al.
Published: (2021-05-01)

Evaluating Pennsylvania Pharmacists’ Provision of Community-based Patient Care Services to Develop a Statewide Practice Network
by: Maria A. Osborne, PharmD, et al.
Published: (2011-01-01)

The Drug Court Pharmacist: Expanding Pharmacy Practice and Addressing Substance Abuse
by: Laura C Palombi, PharmD, et al.
Published: (2016-10-01)

Development and implementation of a physician-pharmacist collaborative practice model for provision and management of buprenorphine/naloxone
by: Lindsay M. Mailloux, PharmD, et al.
Published: (2021-01-01)

Knowledge, Attitude and Practice Related to Chemotherapy Among Cancer Patients
by: Muzna Suhail MPhil, et al.
Published: (2024-04-01)

Alternatives to Hydrocortisone for Hemodynamic Support in Septic Shock Management Due to Medication Shortage
by: Mohammed Aldhaeefi, PharmD, et al.
Published: (2023-07-01)

Proportion of US Hospitalized Medically Ill Patients Who May Qualify for Extended Thromboprophylaxis
by: Benjamin Miao PharmD, et al.
Published: (2019-05-01)

Clinical pharmacist intervention to ensure safe stimulant prescribing practices at a Veterans Affairs facility
by: Bailey B. Bass, PharmD, BCPS, et al.
Published: (2024-02-01)

Survey of prescriptive authority among psychiatric pharmacists in the United States
by: Kelly C. Lee, PharmD, MAS, APh, BCPP, FCCP, et al.
Published: (2023-03-01)

Fanconi Syndrome Induced by Concomitant HIV PrEP and Tacrolimus
by: Becky S. Linn PharmD, et al.
Published: (2021-10-01)

Effect of Pharmacist Audit on Antibiotic Duration for Pneumonia and Urinary Tract Infection
by: Ashley A. Thomas, PharmD, et al.
Published: (2021-08-01)

Post hoc depression analysis from a pharmacist-led diabetes trial
by: M. Thomas Bateman, PharmD, BCACP, et al.
Published: (2023-03-01)

Awareness of and Readiness for Medication Therapy Management Among Community Pharmacists in New York City: Results from a Focus Group
by: Sharrel Pinto, BS Pharm, DMM, MS, PhD, et al.
Published: (2013-01-01)

Retrospective Analysis of Medication Adherence and Cost Following Medication Therapy Management
by: Ashley Branham, PharmD, et al.
Published: (2010-01-01)

A Pharmacist’s Reflection: Living a week, when death’s four seconds away
by: Richard Wenzel, PharmD, CPPS
Published: (2016-10-01)

Ultrasound-Assisted Catheter-Directed Thrombolysis for the Management of Pulmonary Embolism:
by: Jasmine Ventenilla PharmD, et al.
Published: (2024-02-01)

Hyperammonemia in patients receiving valproic acid in the hospital setting: A retrospective review
by: Tressa McMorris, PharmD, BCPS, et al.
Published: (2021-07-01)

Evaluation of the use of chlorpromazine for agitation in pediatric patients
by: Rajwoana Ahmed, PharmD, et al.
Published: (2023-03-01)

Pharmacist-Driven MRSA Nasal PCR Screening and the Duration of Empirical Vancomycin Therapy for Suspected MRSA Respiratory Tract Infections
by: Nathan L. Woolever, PharmD, RPh, et al.
Published: (2020-10-01)